New Class of Compounds can Lead to More Effective Drugs Against Flu

Researchers led by Masahiro Niikura and Nicole Bance at Simon Fraser University have developed a new class of molecular compounds that can be used to develop more effective drugs which flu virus strains cannot easily adapt to.

Their study reveals how to use their newly-discovered compounds to interrupt the enzyme neuraminidase's facilitation of the flu's spread, reports the journal Science Express.

Swine Flu | Swine Influenza | Hog Flu | Pig Flu
Swine flu, a type of influenza caused by a new strain of the H1N1 Type A influenza virus has originated from the pigs. Winter always brings along the chills and the flu, make sure you're safe this season.

Tamiflu and another flu drug, Relenza, focus on interrupting neuraminidase's ability to help flu virus detach from an infected cell's surface by digesting sialic acid, a sugar on the cell surface.

The virus uses the same sugar to stick to the cell while invading it. Once attached, influenza can invade the cell and replicate.

This is where the newly-discovered compounds come to the still-healthy cells' rescue. They clog up neuraminidase, stopping the enzyme from dissolving the sialic acid, which prevents the virus from escaping the infected cell and spreading, according to a Simon Fraser statement.

Avian Influenza / Bird Flu-Causes-Symptoms-Treatment- FAQs
Bird flu (avian influenza/avian flu) is a disease caused by an influenza virus (H5N1) that primarily affects birds but can infect humans also.

The new compounds are also more effective because they are water-soluble. "They reach the patient's throat where the flu virus is replicating after being taken orally," says Niikura, associate professor.

"Influenza develops resistance to Replenza less frequently, but it's not the drug of choice like Tamiflu because it's not water-soluble and has to be taken as a nasal spray.

Hepatitis B-Causes-Symptoms-Diagnosis-Treatment-Vaccination-FAQs
Hepatitis B is inflammation of the liver due to infection with the hepatitis B virus.

"Our new compounds are structurally more similar to sialic acid than Tamiflu. We expect this closer match will make it much more difficult for influenza to adapt to new drugs," adds Niikura.

Ultimately, the new compounds will buy scientists more time to develop new vaccines for emerging strains of influenza that are resistant to existing vaccines.

Source-IANS